Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COSTAIN GROUP PLC Share Issue/Capital Change 2018

Nov 30, 2018

4669_rns_2018-11-30_156910f0-05ff-4b1f-b22b-1e5b47abeb99.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1043J

Costain Group PLC

30 November 2018

Costain Group PLC

("Costain" or the "Company")

Total Voting Rights and Capital

In conformity with the Financial Conduct Authority's ("FCA") Disclosure and Transparency Rule 5.6.1(R) we would like to notify the market of the following:

As at the date of this notice, the Company's issued share capital comprises 107,000,117 ordinary shares of 50 pence each, with each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury. 

The increase in the number of issued shares has arisen due to an allotment of shares to employees who participate in the Company's employee Sharesave Plan.

The figure of 107,000,117 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in Costain, or a change to their interest in Costain, under the FCA's Disclosure and Transparency Rules.

30 November 2018

Enquiries:

Costain Group PLC                                                                                   Tel: 01628 842444

Tracey Wood, Company Secretary

Instinctif Partners Tel: 020 7457 2020
Mark Garraway
James Gray

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVRBSBDBIDXBGIG